The bottom line: Food and beverage suppliers and retailers and restaurant and foodservice operators are likely to see Americans volume of purchases and caloric consumption meaningfully decrease as the burgeoning market for GLP-1 drugs draws more users, PwC said
GLP-1 receptor activation suppresses appetite by slowing gastric emptying, increasing central satiety signalling in the hypothalamus, and triggering glucose-dependent insulin secretion from pancreatic beta cells [1]
Beyond glycemic effects, GLP-1 receptor agonists act on receptors in the central nervous system, particularly in areas regulating appetite and food intake
Figure 1 Accordingly, nave CD4 + T cells isolated from RA patient exhibit diminished glycolytic activity ( + T cells become pathogenic memory and effector T cells, they utilize glucose in a distinctly different manner than nave CD4 + T cells from healthy individuals: they avoid glycolytic breakdown into lactate and instead divert glucose into the PPP, driving the accumulation of NADPH and consumption of cellular reactive oxygen species (ROS)
Their lucrative value in part reflects the fact that many studies are showing them to have therapeutic promise for several indications beyond type-2 diabetes and obesity (Manalac Dec 2024)
After one week, approximately 50 percent of the original dose is still circulating in your system